Hilar Cholangiocarcinoma Clinical Trial
Official title:
Superior Bilioenteric Anastomosis by Magnetic Compressive Technique: A Multicenter, Prospective, Randomized Controlled Trial
The purpose of this study is to determine whether the magnetic compressive anastomosis has a better outcomes than traditional manual anastomosis on superior bilioenteric anastomosis.
The superior bilioenteric anastomosis is one of the most common and difficult operations in
Hepatobiliary Surgery. The traditional manual anastomosis has become one of the main
prognosis factors because of the length of suture time, the difficulty of operation, the high
incidence of anastomotic leakage and stricture. Magnetic compressive anastomosis can realize
the fast anastomosis, reduce the difficulty, and reduce the incidence of anastomotic leakage
and stricture. Currently, the majority of studies of magnetic compressive bilioenteric
anastomosis are merely confined within clinical case report and single-center, small sample,
retrospective study, thus they are lack of convictive evidence of evidence-based medicine for
the security, reliability and convince.
This study is a multicenter, prospective, randomized controlled trial. To evaluate the
security, reliability and convince of magnetic compressive superior bilioenteric anastomosis,
this study compared the incidence of anastomotic leakage and stricture between magnetic
compressive anastomosis and traditional manual anastomosis among patients who need superior
bilioenteric anastomosis operation. The study design plan to enroll 70 patients and divide
into Study Group (Group A: Magnetic compressive anastomosis) and Control Group (Group B:
traditional manual anastomosis) as 1:1 ratio randomly by stratification factors. The
incidence of anastomotic leakage and stricture, length of bilioenteric anastomosis time,
value of serum bilirubin, length of discharge time of magnetic device and mean time of
hospital stay will be evaluated. The patients will drop out of the study if adverse events
happen, active request for dropping out, new-onset severe disease or death. The primary and
secondary end point will be observed by regular follow-up.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05678218 -
Preoperative Evaluation of Lymph Nodes of Cholangiocarcinoma
|
||
Enrolling by invitation |
NCT01715402 -
Optimization of Health Expenditure in Liver Surgery
|
N/A | |
Completed |
NCT03320980 -
RALPPS in Patients With Hilar and Intrahepatic Cholangiocarcinoma
|
N/A | |
Completed |
NCT00721175 -
Efficacy and Cost Analysis of Plastic Stent Compare to Metallic Stent in Hilar Cholangiocarcinoma
|
Phase 4 | |
Recruiting |
NCT05626127 -
MRI-based Clinico-radiomics Predicting Lymph Node Metastasis Status of Hilar Cholangiocarcinoma
|
||
Terminated |
NCT02082522 -
Efficacy and Safety Study of PDT Using Photofrin in Unresectable Advanced Perihilar Cholangiocarcinoma (OPUS)
|
Phase 3 | |
Active, not recruiting |
NCT05239169 -
Immunotherapy With Durva and Treme With or Without Capecitabine in Adjuvant Treatment for Biliary Tract Cancer
|
Phase 2 | |
Recruiting |
NCT02178280 -
Safety Study of Liver Transplantation for Hilar Cholangiocarcinoma
|
Phase 1/Phase 2 | |
Terminated |
NCT02955771 -
Efficacy and Safety Study of PDT Using Deuteporfin for Unresectable Advanced Perihilar Cholangiocarcinoma
|
Phase 2 | |
Recruiting |
NCT03132649 -
Impact of Three-dimensional Visualization on Operation Strategy and Complications for Hilar Cholangiocarcinoma
|
||
Recruiting |
NCT04561453 -
Feasibility Study of Multi-Platform Profiling of Resected Biliary Tract Cancer
|
||
Recruiting |
NCT02108145 -
Percutaneous Bilateral Versus Unilateral Metal Stent for Hilar Cholangiocarcinoma
|
Phase 2/Phase 3 | |
Enrolling by invitation |
NCT03739164 -
Tampa Associating Microwave Liver Ablation With Portal Vein Ligation for Staged Hepatectomy (TAMLAPS)
|
||
Recruiting |
NCT01549795 -
Liver Transplantation for Hilar Cholangiocarcinoma in Association With Neoadjuvant Radio- and Chemo-therapy
|
N/A | |
Recruiting |
NCT06106750 -
Endoscopic Scissors Cutting Nasobiliary Duct VS Bilateral Plastic Stent
|
N/A | |
Active, not recruiting |
NCT02042443 -
Trametinib or Combination Chemotherapy in Treating Patients With Refractory or Advanced Biliary or Gallbladder Cancer or That Cannot Be Removed by Surgery
|
Phase 2 | |
Recruiting |
NCT05551299 -
Treatment of Non-resectable Bile Duct Cancer With Radiofrequency Ablation or Photodynamic Therapy
|
Phase 4 | |
Completed |
NCT01093222 -
Sorafenib Tosylate and Erlotinib Hydrochloride in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gallbladder Cancer or Cholangiocarcinoma
|
Phase 2 | |
Enrolling by invitation |
NCT04779788 -
I-125 Seeds Loaded Stent Insertion for Inoperable Hilar Cholangiocarcinoma
|
N/A | |
Completed |
NCT04611100 -
Efficacy of Intraductal Radiofrequency Ablation in Combination With Metallic Biliary Stenting in Advanced Hilar Cholangiocarcinoma
|
N/A |